Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary Review
Jessica E Burchette1, Kelly Covert1, Patrick Tu2
1Department of Pharmacy Practice, ETSU Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA.
Pivmecillinam is effective for treating uncomplicated acute cystitis, offering a valuable option as antimicrobial resistance grows. Higher doses and longer durations show better results for this common urinary tract infection.
Area of Science:
- Pharmacology and Infectious Diseases
- Antimicrobial Resistance Studies
Background:
- Rising resistance to first-line antimicrobials necessitates novel treatment strategies.
- Pivmecillinam offers a new therapeutic option for uncomplicated acute cystitis in the US.
Purpose of the Study:
- To review evidence on pivmecillinam for uncomplicated acute cystitis.
- To discuss its efficacy, safety, and place in therapy.
Main Methods:
- Literature search of PubMed and ClinicalTrials.gov (2000-2024).
- Included English-language RCTs on pivmecillinam for UTIs in adults.
- MeSH terms: mecillinam, pivmecillinam, urinary tract infections.
Main Results:
- Six RCTs support pivmecillinam for acute uncomplicated cystitis (200-400 mg TID for 3-7 days).
- 400 mg doses and longer durations yielded better clinical and bacteriologic cure rates.
- Limited data exist for pyelonephritis; caution advised.
Conclusions:
- Pivmecillinam is a promising agent for uncomplicated acute cystitis.
- Its use may be cost-driven but is encouraged for susceptible uropathogens due to low resistance.
- Considered a key agent when other treatments fail due to resistance.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Hand hygiene
Hand washing...
